Zealand Pharma is headquartered in Søborg. The biotech company develops new medicines and then typically enters into collaboration agreements with larger pharmaceutical companies that have the capital and capacity to bring the drugs to market. (Archive photo). Photo: Thomas Traasdahl/Ritzau Scanpix
Zealand Pharma shares plunge after new data
Investors reacted with disappointment to data on the weight-loss drug survodutide, presented by Zealand Pharma’s partner, Boehringer Ingelheim. Consequently, the stock fell 22.7 percent on Monday.
Although the drug led to an average weight loss of 16.6 percent, about one in five Phase 3 trial...
Get full access to Danish News in English
Gain exclusive access to daily news updates in English pertaining to Denmark with a Ritzau News subscription.
Already a subscriber?